Literature DB >> 26576505

Adolescent Nonmedical Use of Prescription Pain Relievers, Stimulants, and Depressants, and Suicide Risk.

Keith J Zullig1, Amanda L Divin2, Robert M Weiler3, J David Haddox4, Lisa N Pealer5.   

Abstract

BACKGROUND: Although the link between drug abuse and suicide risk is established, few studies have examined the relationship between the nonmedical use of prescription drugs (NMUPD) and suicide risk, particularly among adolescents.
OBJECTIVES: To explore the relationship between NMUPD and suicide risk among 4,148 adolescents in grades 9-12 enrolled in five public high schools.
METHODS: Logistic regression models were constructed for the nonmedical use of prescription pain relievers, depressants, stimulants, and a composite measure for any NMUPD. Models were estimated before and after controlling for key covariates.
RESULTS: About 21% of respondents reported lifetime NMUPD. After covariate adjustment, students who had reported any NMUPD were between 1.7 and 2.3 times more likely to report suicidal ideation, but not a suicide attempt (p < .0001). When stratified by sex and drug, nonmedical use of pain relievers, stimulants, and depressants were significantly associated with greater odds of suicidal ideation and behavior for both males and females (p < .05). However, NMUPD of pain relievers were not associated with greater odds of suicide attempts for males or females or among males who reported nonmedical use of stimulants. Nonmedical use of depressants was associated with greater odds of suicide attempts for both males and females (OR = 1.61 and 2.25, respectively) and among females who reported nonmedical use of stimulants (OR = 2.06, p < .01). CONCLUSIONS/IMPORTANCE: Results suggest that some adolescents may be inappropriately self-medicating psychological distress with prescription medications or NMUPD may promote suicide risk, especially for males and females who use depressants and females who use stimulants.

Entities:  

Keywords:  adolescents; nonmedical; prescription drugs; suicide

Mesh:

Substances:

Year:  2015        PMID: 26576505     DOI: 10.3109/10826084.2015.1027931

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  7 in total

1.  Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States.

Authors:  Wilson M Compton; Beth Han; Carlos Blanco; Kimberly Johnson; Christopher M Jones
Journal:  Am J Psychiatry       Date:  2018-04-16       Impact factor: 18.112

2.  Prescription opioid and benzodiazepine misuse is associated with suicidal ideation in older adults.

Authors:  Ty S Schepis; Linda Simoni-Wastila; Sean Esteban McCabe
Journal:  Int J Geriatr Psychiatry       Date:  2018-10-16       Impact factor: 3.485

3.  Misuse of Prescription Opioids and Suicidal Behaviors Among Black Adolescents: Findings from the 2017 and 2019 Youth Risk Behavior Survey.

Authors:  Philip Baiden; Danielle R Eugene; Julia K Nicholas; Samantha Spoor; Fawn A Brown; Catherine A LaBrenz
Journal:  J Racial Ethn Health Disparities       Date:  2022-07-21

4.  Race Differences in Opioid Misuse and Adolescent Suicidality.

Authors:  Keith Tsz-Kit Chan; Shangyun Zhou; Christina Marsack-Topolewski
Journal:  Child Adolesc Social Work J       Date:  2020-11-05

5.  Suicidal ideation and attempts following nonmedical use of prescription opioids and related disorder.

Authors:  Julian Santaella-Tenorio; Silvia S Martins; Magdalena Cerdá; Mark Olfson; Katherine M Keyes
Journal:  Psychol Med       Date:  2020-07-08       Impact factor: 7.723

6.  The Use of Non-Prescribed Prescription Drugs and Substance Use Among College Students: A 9-Year Follow-Up Cohort Study.

Authors:  Alicia Busto Miramontes; Lucía Moure-Rodriguez; Ainara Diaz-Geada; Carina Carbia; Fernando Cadaveira; Francisco Caamaño-Isorna
Journal:  Front Psychiatry       Date:  2020-08-27       Impact factor: 4.157

7.  A cross sectional study of non-medical use of prescription opioids and suicidal behaviors among adolescents.

Authors:  Nate Wright; Marizen R Ramirez
Journal:  Inj Epidemiol       Date:  2021-07-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.